Skip to main content
Top
Published in: Journal of Gastroenterology 1/2019

Open Access 01-01-2019 | Original Article—Alimentary Tract

Crohn’s disease-specific mortality: a 30-year cohort study at a tertiary referral center in Japan

Authors: Shigeyoshi Yasukawa, Toshiyuki Matsui, Yutaka Yano, Yuho Sato, Yasumichi Takada, Masahiro Kishi, Yoichiro Ono, Noritaka Takatsu, Takashi Nagahama, Takashi Hisabe, Fumihito Hirai, Kenshi Yao, Toshiharu Ueki, Daijiro Higashi, Kitaro Futami, Suketo Sou, Toshihiro Sakurai, Tsuneyoshi Yao, Hiroshi Tanabe, Akinori Iwashita, Masakazu Washio

Published in: Journal of Gastroenterology | Issue 1/2019

Login to get access

Abstract

Background

In this study, survival and cause of death were investigated in patients with Crohn’s disease (CD) at a tertiary referral center.

Methods

A database was created based on the medical records of 1108 CD patients who had a history of visiting our hospital to investigate background characteristics, cumulative survival rates from diagnosis, causes of death, and the standardized mortality ratio (SMR) for each cause of death. A follow-up questionnaire survey of patients followed up inadequately was also conducted. The cumulative survival rate from diagnosis was determined using the life table method and compared with that of a sex- and age-matched population model from the year 2000.

Results

The study included 1108 patients whose mean age at diagnosis was 25.6 ± 10.8 years. The mean duration of follow-up was 14.6 ± 9.4 years, and there were 52 deaths. The cumulative survival rate was significantly lower 25 years after the diagnosis of CD (91.7%) than in the standard population model (95.7%). SMRs for both all causes [3.5; 95% confidence interval (CI): 2.7–4.6] and CD-specific causes (36.7; 95% CI 26.1–51.6) were high. Among the CD-specific causes, SMRs were especially high for small intestine and colorectal cancers, gastrointestinal diseases including intestinal failure (IF), perioperative complications, and amyloidosis.

Conclusion

The SMRs for both all causes and CD-specific causes were high in CD patients. CD-specific causes including intestinal cancer, IF, perioperative complications, and amyloidosis showed especially high SMRs.
Literature
1.
go back to reference Peyrin-Biroulet L, Loftus EV Jr, Colombel JF, et al. The nature history of adult Crohn’s disease in population based cohorts. Am J Gastroenterol. 2010;105:289–97.PubMedCrossRef Peyrin-Biroulet L, Loftus EV Jr, Colombel JF, et al. The nature history of adult Crohn’s disease in population based cohorts. Am J Gastroenterol. 2010;105:289–97.PubMedCrossRef
2.
go back to reference Lakatos PL, Golovics PA, David G, et al. Has there been a change in the natural history of Crohn’s disease? Surgical rates and medical management in a population-based inception cohort from Western Hungary between 1977–2009. Am J Gastroenterol. 2012;107:579–88.PubMedCrossRef Lakatos PL, Golovics PA, David G, et al. Has there been a change in the natural history of Crohn’s disease? Surgical rates and medical management in a population-based inception cohort from Western Hungary between 1977–2009. Am J Gastroenterol. 2012;107:579–88.PubMedCrossRef
3.
go back to reference Sato Y, Matsui T, Yano Y, et al. Long-term course of Crohn’s disease in Japan: incidence of complications, cumulative rate of initial surgery, and risk factors at diagnosis for initial surgery. J Gastroenterol Hepatol. 2015;30:1713–9.PubMedCrossRef Sato Y, Matsui T, Yano Y, et al. Long-term course of Crohn’s disease in Japan: incidence of complications, cumulative rate of initial surgery, and risk factors at diagnosis for initial surgery. J Gastroenterol Hepatol. 2015;30:1713–9.PubMedCrossRef
5.
go back to reference Uno H, Yao T, Matsui T, et al. Mortality and cause of death in Japanese patients with Crohn’s disease. Dis Colon Rectum. 2003;46:S15–21.PubMed Uno H, Yao T, Matsui T, et al. Mortality and cause of death in Japanese patients with Crohn’s disease. Dis Colon Rectum. 2003;46:S15–21.PubMed
6.
go back to reference Oriuchi T, Hiwatashi N, Kinouchi Y, et al. Clinical course and longterm prognosis of Japanese patients with Crohn’s disease: predictive factors, rates of operation, and mortality. J Gastroenterol. 2003;38:942–53.PubMedCrossRef Oriuchi T, Hiwatashi N, Kinouchi Y, et al. Clinical course and longterm prognosis of Japanese patients with Crohn’s disease: predictive factors, rates of operation, and mortality. J Gastroenterol. 2003;38:942–53.PubMedCrossRef
7.
go back to reference Wolters FL, Russel MG, Sijbrandij j, et al. Crohn’s disease: increased mortality 10 years after diagnosis in a Europe-wide population based cohort. Gut. 2006;55:510–8.PubMedPubMedCentralCrossRef Wolters FL, Russel MG, Sijbrandij j, et al. Crohn’s disease: increased mortality 10 years after diagnosis in a Europe-wide population based cohort. Gut. 2006;55:510–8.PubMedPubMedCentralCrossRef
8.
go back to reference Jess T, Loftus EV Jr, Harmsen WS, et al. Survival and cause specific mortality in patients with inflammatory bowel disease: a long term outcome study in Olmsted Country, Minnesota, 1940–2004. Gut. 2006;55:1248–54.PubMedPubMedCentralCrossRef Jess T, Loftus EV Jr, Harmsen WS, et al. Survival and cause specific mortality in patients with inflammatory bowel disease: a long term outcome study in Olmsted Country, Minnesota, 1940–2004. Gut. 2006;55:1248–54.PubMedPubMedCentralCrossRef
9.
go back to reference Canavan C, Abrams KR, Mayberry JF. Meta-analysis: mortality in Crohn’s disease. Aliment Pharmacol Ther. 2007;25:861–70.PubMedCrossRef Canavan C, Abrams KR, Mayberry JF. Meta-analysis: mortality in Crohn’s disease. Aliment Pharmacol Ther. 2007;25:861–70.PubMedCrossRef
10.
go back to reference Jess T, Riis L, Vind I, et al. Changes in clinical characteristics, course, and prognosis of inflammatory bowel disease during the last 5 decades: a population-based study from Copenhagen, Denmark. Inflamm Bowel Dis. 2007;13:481–9.PubMedCrossRef Jess T, Riis L, Vind I, et al. Changes in clinical characteristics, course, and prognosis of inflammatory bowel disease during the last 5 decades: a population-based study from Copenhagen, Denmark. Inflamm Bowel Dis. 2007;13:481–9.PubMedCrossRef
11.
go back to reference Selinger CP, Andrews J, Dent OF, et al. Cause-specific mortality and 30-year relative survival of Crohn’s disease and ulcerative colitis. Inflamm Bowel Dis. 2013;19:1880–8.PubMedCrossRef Selinger CP, Andrews J, Dent OF, et al. Cause-specific mortality and 30-year relative survival of Crohn’s disease and ulcerative colitis. Inflamm Bowel Dis. 2013;19:1880–8.PubMedCrossRef
12.
go back to reference Hovde Ø, Kempski-Monstad I, Småstuen MC, et al. Mortality and causes of death in Crohn’s disease: results from 20 years of follow-up in the IBSEN study. Gut. 2014;63:771–5.PubMedCrossRef Hovde Ø, Kempski-Monstad I, Småstuen MC, et al. Mortality and causes of death in Crohn’s disease: results from 20 years of follow-up in the IBSEN study. Gut. 2014;63:771–5.PubMedCrossRef
13.
go back to reference Bitton A, Vutcovici M, Sewitch M, et al. Mortality trends in crohn’s disease and ulcerative colitis: a population-based study in Québec, Canada. Inflamm Bowel Dis. 2016;22:416–23.PubMedCrossRef Bitton A, Vutcovici M, Sewitch M, et al. Mortality trends in crohn’s disease and ulcerative colitis: a population-based study in Québec, Canada. Inflamm Bowel Dis. 2016;22:416–23.PubMedCrossRef
14.
go back to reference Lee HS, Choe J, Kim SO, et al. Overall and cause-specific mortality in Korean patients with inflammatory bowel disease: a hospital-based cohort study. J Gastroenterol Hepatol. 2017;32:782–8.PubMedCrossRef Lee HS, Choe J, Kim SO, et al. Overall and cause-specific mortality in Korean patients with inflammatory bowel disease: a hospital-based cohort study. J Gastroenterol Hepatol. 2017;32:782–8.PubMedCrossRef
15.
go back to reference Matsui T, Hirai F, Hisabe T. Proposed diagnostic criteria for Crohn’s disease. In: Annual of Research Group of Intractable Inflammatory Bowel Disease subsidized by the Ministry of Health, Labour, and Welfare of Japan. 2011, pp. 52–54 (in Japanese). Matsui T, Hirai F, Hisabe T. Proposed diagnostic criteria for Crohn’s disease. In: Annual of Research Group of Intractable Inflammatory Bowel Disease subsidized by the Ministry of Health, Labour, and Welfare of Japan. 2011, pp. 52–54 (in Japanese).
16.
go back to reference Ueno F, Matsui T, Matsumoto T, et al. Evidence-based clinical practice guidelines for Crohn’s disease, integrated with formal consensus of experts in Japan. J Gastroenterol. 2013;48:31–72.PubMedCrossRef Ueno F, Matsui T, Matsumoto T, et al. Evidence-based clinical practice guidelines for Crohn’s disease, integrated with formal consensus of experts in Japan. J Gastroenterol. 2013;48:31–72.PubMedCrossRef
17.
go back to reference Hisabe T, Hirai F, Matsui T, et al. Evaluation of diagnostic criteria for Crohn’s disease in Japan. J Gastoenterol. 2014;49:93–9.CrossRef Hisabe T, Hirai F, Matsui T, et al. Evaluation of diagnostic criteria for Crohn’s disease in Japan. J Gastoenterol. 2014;49:93–9.CrossRef
18.
go back to reference Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005;19:5–36.CrossRef Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005;19:5–36.CrossRef
19.
go back to reference Kim HJ, Hann HJ, Hong SN, et al. Incidence and natural course of inflammatory bowel disease in Korea, 2006-2012: a nationwide population-based study. Inflamm Bowel Dis. 2015;21:623–30.PubMedCrossRef Kim HJ, Hann HJ, Hong SN, et al. Incidence and natural course of inflammatory bowel disease in Korea, 2006-2012: a nationwide population-based study. Inflamm Bowel Dis. 2015;21:623–30.PubMedCrossRef
21.
go back to reference Prior P, Gyde S, Cooke WT, et al. Mortality in Crohn’s disease. Gastroenterology. 1981;80:307–12.PubMedCrossRef Prior P, Gyde S, Cooke WT, et al. Mortality in Crohn’s disease. Gastroenterology. 1981;80:307–12.PubMedCrossRef
22.
go back to reference Weterman IT, Biemond I, Peña AS. Mortality and cause of death in Crohn’s disease: review of 50 years’ experience in Leiden University Hospital. Gut. 1990;31:1387–90.PubMedPubMedCentralCrossRef Weterman IT, Biemond I, Peña AS. Mortality and cause of death in Crohn’s disease: review of 50 years’ experience in Leiden University Hospital. Gut. 1990;31:1387–90.PubMedPubMedCentralCrossRef
23.
go back to reference Cottone M, Magliocco A, Rosselli M, et al. Mortality in patients with Crohn’s disease. Scand J Gastroenterol. 1996;31:372–5.PubMedCrossRef Cottone M, Magliocco A, Rosselli M, et al. Mortality in patients with Crohn’s disease. Scand J Gastroenterol. 1996;31:372–5.PubMedCrossRef
24.
go back to reference Farrokhyar F, Swarbrick ET, Grace RH, et al. Low mortality in ulcerative colitis and Crohn’s disease in three regional centers in England. Am J Gastroenterol. 2001;96:501–7.PubMedCrossRef Farrokhyar F, Swarbrick ET, Grace RH, et al. Low mortality in ulcerative colitis and Crohn’s disease in three regional centers in England. Am J Gastroenterol. 2001;96:501–7.PubMedCrossRef
25.
go back to reference Kennedy NA, Clark DN, Bauer J, et al. Nationwide linkage analysis in Scotland to assess mortality following hospital admission for Crohn’s disease: 1998–2000. Aliment Pharmacol Ther. 2012;35:142–53.PubMedCrossRef Kennedy NA, Clark DN, Bauer J, et al. Nationwide linkage analysis in Scotland to assess mortality following hospital admission for Crohn’s disease: 1998–2000. Aliment Pharmacol Ther. 2012;35:142–53.PubMedCrossRef
26.
go back to reference Hutfless SM, Weng X, Liu L, et al. Mortality by medication use among patients with inflammatory bowel disease, 1996–2003. Gastroenterology. 2007;133:1779–86.PubMedCrossRef Hutfless SM, Weng X, Liu L, et al. Mortality by medication use among patients with inflammatory bowel disease, 1996–2003. Gastroenterology. 2007;133:1779–86.PubMedCrossRef
27.
go back to reference Masala G, Bagnoli S, Ceroti M, et al. Divergent patterns of total and cancer mortality in ulcerative colitis and Crohn’s disease patients: the Florence IBD study 1978–2001. Gut. 2004;53:1309–13.PubMedPubMedCentralCrossRef Masala G, Bagnoli S, Ceroti M, et al. Divergent patterns of total and cancer mortality in ulcerative colitis and Crohn’s disease patients: the Florence IBD study 1978–2001. Gut. 2004;53:1309–13.PubMedPubMedCentralCrossRef
28.
go back to reference Watanabe K, Sasaki I, Fukushima K, et al. Long-term incidence and characteristics of intestinal failure in Crohn’s disease: a multicenter study. J Gastroenterol. 2014;49:231–8.PubMedCrossRef Watanabe K, Sasaki I, Fukushima K, et al. Long-term incidence and characteristics of intestinal failure in Crohn’s disease: a multicenter study. J Gastroenterol. 2014;49:231–8.PubMedCrossRef
29.
go back to reference Howard L, Malone M. Current status of home parenteral nutrition in the United States. Transplant Proc. 1996;28:2691–5.PubMed Howard L, Malone M. Current status of home parenteral nutrition in the United States. Transplant Proc. 1996;28:2691–5.PubMed
30.
go back to reference Loly C, Belaiche J, Louis E. Predictors of severe Crohn’s disease. Scand J Gastroenterol. 2008;43:948–54.PubMedCrossRef Loly C, Belaiche J, Louis E. Predictors of severe Crohn’s disease. Scand J Gastroenterol. 2008;43:948–54.PubMedCrossRef
31.
go back to reference Limketkai BN, Parian AM, Shah ND, et al. Short bowel syndrome and intestinal failure in Crohn’s disease. Inflamm Bowel Dis. 2016;22:1209–18.PubMedCrossRef Limketkai BN, Parian AM, Shah ND, et al. Short bowel syndrome and intestinal failure in Crohn’s disease. Inflamm Bowel Dis. 2016;22:1209–18.PubMedCrossRef
32.
go back to reference Caini S, Bagnoli S, Palli D, et al. Total and cancer mortality in a cohort of ulcerative colitis and Crohn’s disease patients: the Florence inflammatory bowel disease study, 1978–2010. Dig Liver Dis. 2016;48:1162–7.PubMedCrossRef Caini S, Bagnoli S, Palli D, et al. Total and cancer mortality in a cohort of ulcerative colitis and Crohn’s disease patients: the Florence inflammatory bowel disease study, 1978–2010. Dig Liver Dis. 2016;48:1162–7.PubMedCrossRef
33.
go back to reference Canavan C, Abrams KR, Mayberry J. Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn’s disease. Aliment Pharmacol Ther. 2006;23:1097–104.PubMedCrossRef Canavan C, Abrams KR, Mayberry J. Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn’s disease. Aliment Pharmacol Ther. 2006;23:1097–104.PubMedCrossRef
34.
go back to reference Yano Y, Matsui T, Hirai F, et al. Cancer risk in Japanese Crohn’s disease patients: investigation of the standardized incidence ratio. J Gastroenterol Hepatol. 2013;28:1300–5.PubMedCrossRef Yano Y, Matsui T, Hirai F, et al. Cancer risk in Japanese Crohn’s disease patients: investigation of the standardized incidence ratio. J Gastroenterol Hepatol. 2013;28:1300–5.PubMedCrossRef
35.
go back to reference Mizushima T, Ohno Y, Nakajima K, et al. Malignancy in Crohn’s disease: incidence and clinical characteristics in Japan. Digestion. 2010;81:265–70.PubMedCrossRef Mizushima T, Ohno Y, Nakajima K, et al. Malignancy in Crohn’s disease: incidence and clinical characteristics in Japan. Digestion. 2010;81:265–70.PubMedCrossRef
36.
go back to reference Higashi D, Katsuno H, Kimura H, et al. Current state of and problems related to cancer of the intestinal tract associated with Crohn’s disease in Japan. Anticancer Res. 2016;36:3761–6.PubMed Higashi D, Katsuno H, Kimura H, et al. Current state of and problems related to cancer of the intestinal tract associated with Crohn’s disease in Japan. Anticancer Res. 2016;36:3761–6.PubMed
37.
go back to reference Sugita A, Koganei K, Tatsumi K, et al. Management of rectal cancer including cancer in the anal fistula with Crohn’s disease. Nihon Shokakibyo Gakkai Zasshi. 2013;110:396–402.PubMed Sugita A, Koganei K, Tatsumi K, et al. Management of rectal cancer including cancer in the anal fistula with Crohn’s disease. Nihon Shokakibyo Gakkai Zasshi. 2013;110:396–402.PubMed
38.
go back to reference Yamamoto J, Uno H, Hirai F, et al. Clinical study of 11 cases of amyloidosis secondary to Crohn’s disease (in Japanese). Stomach Intestine. 1999;34:1255–66. Yamamoto J, Uno H, Hirai F, et al. Clinical study of 11 cases of amyloidosis secondary to Crohn’s disease (in Japanese). Stomach Intestine. 1999;34:1255–66.
39.
go back to reference Tanimura S, Nozaki R, Ohwan T, et al. Clinical study of secondary amyloidosis in surgically treated cases of Crohn’s disease (in Japanese). J Jpn Soc Coloproctol. 2006;59:441–7.CrossRef Tanimura S, Nozaki R, Ohwan T, et al. Clinical study of secondary amyloidosis in surgically treated cases of Crohn’s disease (in Japanese). J Jpn Soc Coloproctol. 2006;59:441–7.CrossRef
40.
go back to reference Miyaoka M, Matsui T, Hisabe T, et al. Clinical and endoscopic features of amyloidosis secondary to Crohn’s disease: diagnostic value of duodenal observation and biopsy. Dig Endosc. 2011;23:157–65.PubMedCrossRef Miyaoka M, Matsui T, Hisabe T, et al. Clinical and endoscopic features of amyloidosis secondary to Crohn’s disease: diagnostic value of duodenal observation and biopsy. Dig Endosc. 2011;23:157–65.PubMedCrossRef
41.
go back to reference Sharma P, Aguilar R, Siddiqui OA, et al. Secondary systemic amyloidosis in inflammatory bowel disease: a nationwide analysis. Ann Gastroenterol. 2017;30:504–11.PubMedPubMedCentral Sharma P, Aguilar R, Siddiqui OA, et al. Secondary systemic amyloidosis in inflammatory bowel disease: a nationwide analysis. Ann Gastroenterol. 2017;30:504–11.PubMedPubMedCentral
42.
go back to reference Tosca Cuquerella J, Bosca-Watts MM, Anton Ausejo R, et al. Amyloidosis in inflammatory bowel disease: a systematic review of epidemiology, clinical features, and treatment. J Crohns Colitis. 2016;10:1245–53.PubMedCrossRef Tosca Cuquerella J, Bosca-Watts MM, Anton Ausejo R, et al. Amyloidosis in inflammatory bowel disease: a systematic review of epidemiology, clinical features, and treatment. J Crohns Colitis. 2016;10:1245–53.PubMedCrossRef
43.
go back to reference Lowdell CP, Shousha S, Parkins RA. The incidence of amyloidosis complicating inflammatory bowel disease. A prospective survey of 177 patients. Dis Colon Rectum. 1986;29:351–4.PubMedCrossRef Lowdell CP, Shousha S, Parkins RA. The incidence of amyloidosis complicating inflammatory bowel disease. A prospective survey of 177 patients. Dis Colon Rectum. 1986;29:351–4.PubMedCrossRef
44.
go back to reference Rutgeerts P, D’Haens G, Targan S, et al. Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn’s disease. Gastroenterology. 1999;117:761–9.PubMedCrossRef Rutgeerts P, D’Haens G, Targan S, et al. Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn’s disease. Gastroenterology. 1999;117:761–9.PubMedCrossRef
45.
go back to reference Hanauer SB, Feagan BG, Lichtenstein GR, et al. Maintenance infliximab for Crohn’s disease: the ACCENT I randomised trial. Lancet. 2002;359:1541–9.PubMedCrossRef Hanauer SB, Feagan BG, Lichtenstein GR, et al. Maintenance infliximab for Crohn’s disease: the ACCENT I randomised trial. Lancet. 2002;359:1541–9.PubMedCrossRef
46.
go back to reference Sands BE, Anderson FH, Bernstein CN, et al. Infliximab maintenance therapy for fistulizing Crohn’s disease. N Engl J Med. 2004;350:876–85.PubMedCrossRef Sands BE, Anderson FH, Bernstein CN, et al. Infliximab maintenance therapy for fistulizing Crohn’s disease. N Engl J Med. 2004;350:876–85.PubMedCrossRef
47.
go back to reference Rungoe C, Langholz E, Andersson M, et al. Changes in medical treatment and surgery rates in inflammatory bowel disease: a nationwide cohort study 1979–2011. Gut. 2014;63:1607–16.PubMedCrossRef Rungoe C, Langholz E, Andersson M, et al. Changes in medical treatment and surgery rates in inflammatory bowel disease: a nationwide cohort study 1979–2011. Gut. 2014;63:1607–16.PubMedCrossRef
Metadata
Title
Crohn’s disease-specific mortality: a 30-year cohort study at a tertiary referral center in Japan
Authors
Shigeyoshi Yasukawa
Toshiyuki Matsui
Yutaka Yano
Yuho Sato
Yasumichi Takada
Masahiro Kishi
Yoichiro Ono
Noritaka Takatsu
Takashi Nagahama
Takashi Hisabe
Fumihito Hirai
Kenshi Yao
Toshiharu Ueki
Daijiro Higashi
Kitaro Futami
Suketo Sou
Toshihiro Sakurai
Tsuneyoshi Yao
Hiroshi Tanabe
Akinori Iwashita
Masakazu Washio
Publication date
01-01-2019
Publisher
Springer Singapore
Published in
Journal of Gastroenterology / Issue 1/2019
Print ISSN: 0944-1174
Electronic ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-018-1482-y

Other articles of this Issue 1/2019

Journal of Gastroenterology 1/2019 Go to the issue